Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes

Background In the current SARS-CoV-2 pandemic, there has been worldwide debate on the use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of dexamethasone, a reduced 28-day mortality in patients requiring oxygen therapy or mechanical ventilation was shown. Their results have led to considering amendments in guidelines or actually already recommending corticosteroids in COVID-19. However, the effectiveness and safety of corticosteroids still remain uncertain, and reliable data to further shed light on the benefit and harm are needed. Objectives The aim of this systematic review and meta-analysis was to evaluate the effectiveness and safety of corticosteroids in COVID-19. Methods A systematic literature search of RCTS and observational studies on adult patients was performed across Medline/PubMed, Embase and Web of Science from December 1, 2019, until October 1, 2020, according to the PRISMA guidelines. Primary outcomes were short-term mortality and viral clearance (based on RT-PCR in respiratory specimens). Secondary outcomes were: need for mechanical ventilation, need for other oxygen therapy, length of hospital stay and secondary infections. Results Forty-four studies were included, covering 20.197 patients. In twenty-two studies, the effect of corticosteroid use on mortality was quantified. The overall pooled estimate (observational studies and RCTs) showed a significant reduced mortality in the corticosteroid group (OR 0.72 (95%CI 0.57–0.87). Furthermore, viral clearance time ranged from 10 to 29 days in the corticosteroid group and from 8 to 24 days in the standard of care group. Fourteen studies reported a positive effect of corticosteroids on need for and duration of mechanical ventilation. A trend toward more infections and antibiotic use was present. Conclusions Our findings from both observational studies and RCTs confirm a beneficial effect of corticosteroids on short-term mortality and a reduction in need for mechanical ventilation. And although data in the studies were too sparse to draw any firm conclusions, there might be a signal of delayed viral clearance and an increase in secondary infections..

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:24

Enthalten in:

Critical care - 24(2020), 1 vom: 14. Dez.

Sprache:

Englisch

Beteiligte Personen:

van Paassen, Judith [VerfasserIn]
Vos, Jeroen S. [VerfasserIn]
Hoekstra, Eva M. [VerfasserIn]
Neumann, Katinka M. I. [VerfasserIn]
Boot, Pauline C. [VerfasserIn]
Arbous, Sesmu M. [VerfasserIn]

Links:

Volltext [kostenfrei]

BKL:

44.00 / Medizin: Allgemeines / Medizin: Allgemeines

Themen:

COVID-19
Coronavirus
Corticosteroids
Mechanical ventilation
Mortality
SARS-CoV-2
Viral clearance

Anmerkungen:

© The Author(s) 2020

doi:

10.1186/s13054-020-03400-9

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC2122027304

Zugang & Verfügbarkeit




Zugehörige Publikationen/Bände

    Haven't found what you're looking for?